↓ Skip to main content

A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment…

Overview of attention for article published in BMC Cancer, June 2013
Altmetric Badge

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
30 Mendeley